Bridgebio Pharma Inc (BBIO)

Deferred Revenue

$5.55M

Quarterly · Period ending: · USD

BBIO logo

BBIO Deferred Revenue

Latest reported$5.55M
BBIO Quarterly Deferred Revenue ($0.00 → $5.55M)
High-resolution chart · PNG

BBIO deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
5,546,000
17,891,000
20,270,000
9,087,000
10,540,000
0
0
11,771,000
15,098,000
13,957,000
6,096,000
0
0
6,675,000
8,156,000
7,518,000
7,190,000
0
0
0
1,600,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.